Better technologies for better medicines
Our cutting-edge AI-driven platform delivers potential best-in-class and first-in-class medicines, optimized for patient and partner impact
Optimized medicines for optimized profiles
Our AI technologies, Enchant and NeuralPLexer, drive a high-throughput experimental platform that converts novel molecular designs into biological insights each week
Exploring multiple profiles in parallel ensures that we design molecules to solve the right problems in disease biology
Our AI-driven platform deeply explores chemical space, revealing novel mechanisms of action and delivering diverse high-quality leads
Innovation
Multimodal transformer and co-folding AI technologies built for the purpose of drug discovery
Automation
AI-driven, high-throughput experimentation to go from new molecular designs to new biological data each week
Execution
A proprietary pipeline of differentiated clinical candidates delivered at a pace years faster than the industry standard
Platform-driven pipeline of first-in-class and best-in-class programs
We are unlocking the untapped potential of known targets and transforming seemingly undruggable targets into opportunities for breakthrough treatments.
Highly selective, brain-penetrant inhibitor for HER2-driven cancers that has shown anti-tumor activity, safety and tolerability in Phase 1/1b studies.
Potential best-in-class, brain-penetrant inhibitor for breast cancer, ovarian cancer, and other solid tumors.
A potent, highly selective CDK2/4 small-molecule inhibitor for HR+/HER2- metastatic breast cancer.
Innovation through the collaboration of AI experts and drug hunters
By placing AI innovations in the hands of our seasoned drug hunters, we’re optimizing our path towards differentiated therapeutics.
.jpg)
News & Media
Read our recent announcements
